Health Care·Health Care Equipment·$43.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.55 | N/A | +44.81% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $4.55 | N/A | +44.81% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed confidence in their product pipeline and market position. They acknowledged current challenges but emphasized resilience.
Management highlighted strong performance in their diagnostics segment.
They noted ongoing challenges in supply chain but remain focused on long-term growth.
Becton Dickinson's strong EPS performance indicates better-than-expected profitability, but the stock declined by 2.31% likely due to the lack of revenue data and guidance. Investors may be cautious given the ongoing supply chain challenges mentioned by management. Overall, the strong EPS surprise suggests potential for future growth, but uncertainty remains.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ON SEMICONDUCTOR COR
Feb 1, 2021